Early tumour shrinkage and EGFR-inhibitor therapy of mCRC; primary tumour resection in case of non-resectable distant metastases/de-bulking & the practice changing RESORCE trial in in refractory liver

Prof. Dr. med. Ulrich Güller, Kantonsspital St.Gallen:


Immunotherapy of mCRC

Dr. Andreas Wicki, Universitätsspital Basel:


Treatment of patients with BRAF mt tumours

PD Dr. med. Thomas Winder, UniversitätsSpital Zürich: